JP2002534393A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002534393A5 JP2002534393A5 JP2000592015A JP2000592015A JP2002534393A5 JP 2002534393 A5 JP2002534393 A5 JP 2002534393A5 JP 2000592015 A JP2000592015 A JP 2000592015A JP 2000592015 A JP2000592015 A JP 2000592015A JP 2002534393 A5 JP2002534393 A5 JP 2002534393A5
- Authority
- JP
- Japan
- Prior art keywords
- growth hormone
- transplantation
- induces
- initiated
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000018997 Growth Hormone Human genes 0.000 description 4
- 108010051696 Growth Hormone Proteins 0.000 description 4
- 239000000122 growth hormone Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002634 anti-blastic effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000010322 bone marrow transplantation Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 238000011134 hematopoietic stem cell transplantation Methods 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000001400 myeloablative effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98124834A EP1016413A1 (en) | 1998-12-30 | 1998-12-30 | Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| EP98124834.7 | 1998-12-30 | ||
| PCT/EP1999/010470 WO2000040260A1 (en) | 1998-12-30 | 1999-12-30 | Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002534393A JP2002534393A (ja) | 2002-10-15 |
| JP2002534393A5 true JP2002534393A5 (https=) | 2010-11-18 |
| JP4808316B2 JP4808316B2 (ja) | 2011-11-02 |
Family
ID=8233268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000592015A Expired - Fee Related JP4808316B2 (ja) | 1998-12-30 | 1999-12-30 | 多能性造血幹細胞の動員を刺激するためのヒト成長ホルモン |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20060029581A1 (https=) |
| EP (3) | EP1016413A1 (https=) |
| JP (1) | JP4808316B2 (https=) |
| AT (1) | ATE342064T1 (https=) |
| AU (2) | AU772222B2 (https=) |
| BR (1) | BR9916726A (https=) |
| CA (1) | CA2354194A1 (https=) |
| CY (1) | CY1107603T1 (https=) |
| DE (1) | DE69933581T2 (https=) |
| DK (1) | DK1140149T3 (https=) |
| ES (1) | ES2275359T3 (https=) |
| IL (2) | IL143994A0 (https=) |
| PT (1) | PT1140149E (https=) |
| SI (1) | SI1140149T1 (https=) |
| WO (1) | WO2000040260A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL153288A0 (en) * | 2000-06-07 | 2003-07-06 | Applied Research Systems | Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis |
| JP2004504834A (ja) | 2000-08-01 | 2004-02-19 | イスム リサーチ ディベロップメント カンパニー | 胚性細胞の定方向分化 |
| DK1411918T3 (da) * | 2001-07-31 | 2012-04-23 | Genzyme Global S A R L | Fremgangsmåder til at mobilisere progenitor/stamceller |
| WO2005032572A2 (en) | 2003-10-03 | 2005-04-14 | Vib Vzw | Means and methods for the recruitment and identification of stem cells |
| JP2005289837A (ja) * | 2004-03-31 | 2005-10-20 | Juntendo | 骨髄細胞誘導剤の製造方法及び製造装置 |
| CN103520735B (zh) * | 2004-12-22 | 2015-11-25 | Ambrx公司 | 包含非天然编码的氨基酸的人生长激素配方 |
| BR112012015597A2 (pt) * | 2009-12-21 | 2017-01-31 | Ambrx Inc | peptídeos de somatotropina suínos modificados e seus usos |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5649904A (en) * | 1988-10-07 | 1997-07-22 | Sandoz Ltd. | Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both |
| US5199942A (en) * | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
| EP0563485A1 (en) * | 1992-03-30 | 1993-10-06 | Schering-Plough | In vitro generation of human dendritic cells and uses thereof |
| JPH08511263A (ja) * | 1993-06-15 | 1996-11-26 | ブリテッシュ バイオテック ファーマシューティカルズ リミテッド | 造血細胞の放出と可動化 |
| JPH07101877A (ja) * | 1993-10-04 | 1995-04-18 | Mitsui Toatsu Chem Inc | 血小板減少症治療剤 |
| IL111181A0 (en) * | 1993-10-06 | 1994-12-29 | Univ Florida | Stem cell proliferation factor, its preparation, purification and uses |
| JPH0892001A (ja) * | 1994-09-26 | 1996-04-09 | Asahi Medical Co Ltd | 細胞集団の保存方法 |
| JPH11509845A (ja) * | 1995-07-21 | 1999-08-31 | アメリカ合衆国 | 造血多分化性細胞移植のための放射線または放射線類似作用化学療法の減少方法 |
| JP2000503542A (ja) * | 1996-01-16 | 2000-03-28 | デピュイ オーソピーディック，インコーポレイテッド | 造血及び非造血組織からの前駆細胞の分離及び ｉｎ ｖｉｖｏ 骨及び軟骨再生におけるそれらの使用 |
| JP4042925B2 (ja) * | 1996-11-20 | 2008-02-06 | シスメックス株式会社 | 幼若白血球の分類計数法 |
| JPH10295369A (ja) * | 1997-02-26 | 1998-11-10 | Japan Tobacco Inc | 造血幹細胞の製造方法 |
| SE9804064D0 (sv) * | 1998-11-25 | 1998-11-25 | A & Science Invest Ab | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| EP1016414B1 (en) * | 1998-12-17 | 2004-09-08 | Applied Research Systems ARS Holding N.V. | Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans |
| IL153288A0 (en) * | 2000-06-07 | 2003-07-06 | Applied Research Systems | Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis |
| US7220407B2 (en) * | 2003-10-27 | 2007-05-22 | Amgen Inc. | G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
-
1998
- 1998-12-30 EP EP98124834A patent/EP1016413A1/en not_active Withdrawn
-
1999
- 1999-12-30 DK DK99965579T patent/DK1140149T3/da active
- 1999-12-30 PT PT99965579T patent/PT1140149E/pt unknown
- 1999-12-30 AU AU21039/00A patent/AU772222B2/en not_active Ceased
- 1999-12-30 BR BR9916726-3A patent/BR9916726A/pt not_active Application Discontinuation
- 1999-12-30 WO PCT/EP1999/010470 patent/WO2000040260A1/en not_active Ceased
- 1999-12-30 DE DE69933581T patent/DE69933581T2/de not_active Expired - Lifetime
- 1999-12-30 AT AT99965579T patent/ATE342064T1/de active
- 1999-12-30 SI SI9930937T patent/SI1140149T1/sl unknown
- 1999-12-30 ES ES99965579T patent/ES2275359T3/es not_active Expired - Lifetime
- 1999-12-30 CA CA002354194A patent/CA2354194A1/en not_active Abandoned
- 1999-12-30 JP JP2000592015A patent/JP4808316B2/ja not_active Expired - Fee Related
- 1999-12-30 EP EP06021178A patent/EP1779865A1/en not_active Withdrawn
- 1999-12-30 IL IL14399499A patent/IL143994A0/xx unknown
- 1999-12-30 EP EP99965579A patent/EP1140149B1/en not_active Expired - Lifetime
-
2001
- 2001-06-26 IL IL143994A patent/IL143994A/en not_active IP Right Cessation
-
2004
- 2004-07-22 AU AU2004203355A patent/AU2004203355B2/en not_active Ceased
-
2005
- 2005-09-29 US US11/237,876 patent/US20060029581A1/en not_active Abandoned
-
2007
- 2007-01-08 CY CY20071100021T patent/CY1107603T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Reichenspurner et al. | Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis | |
| US20170157291A1 (en) | Tissue transplant compositions and methods for use | |
| CA2387542A1 (en) | Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation | |
| DK0633721T3 (da) | Rensning af blodplader med 8-metoxypsoralen | |
| ATE153856T1 (de) | Zusammensetzung zur stimulierung des immunsystems | |
| CA2208047A1 (en) | Increasing creatine and glycogen concentration in muscle | |
| JP2018537472A (ja) | 増殖造血幹細胞／前駆細胞集団の利用 | |
| IL153288A0 (en) | Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis | |
| JP2002534393A5 (https=) | ||
| KR950700079A (ko) | 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease) | |
| DE60313356D1 (de) | Verwendungvon dextransulfat zur behandlung von ibmir | |
| BR9914644A (pt) | Composições tamponadas para diálise | |
| JP2008531696A5 (https=) | ||
| Carella et al. | Autografting in chronic myeloid leukemia | |
| JP2000178203A5 (https=) | ||
| Lindvall et al. | First step towards cell therapy for Huntington's disease. | |
| JP2005506959A5 (https=) | ||
| WO2008045528A3 (en) | Methods and compositions for the treatment of cancer | |
| EP1016414A3 (en) | Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans | |
| Borgies et al. | Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation | |
| Villaron et al. | Bone marrow mesenchymal stem cells chimerism after allogeneic hematopoietic transplantation | |
| Kalvit | De novo histoid leprosy in an immunocompetent male: a rare case report from North east India | |
| ATE335494T1 (de) | Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen | |
| SE0200598D0 (sv) | Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences | |
| 宋伯铮 et al. | CLINICAL OBSERVATION OF 74 REVASCULARIZED OSTEOMYOCUTANEOUS FLAP GRAFTS TO RECONSTRUCT THE MANDIBULAR DEFECTS |